Vyndaqel TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tafamidis
Pack: Vyndaqel 20 mg capsule, 30, blister pack
Brand name
(ARTG)
: VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister packWhat this medicine is used for
(ARTG)
VYNDAQEL is indicated for the treatment of adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM)
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, soft
- Oral
- Yellow, opaque, oblong (approximately 21 mm) capsule printed with VYN 20 in red.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tafamidis
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
